F18.9
Inhalant use, unspecified
Clinical Classification Guidelines
Excludes Type 1
- inhalant abuse (F18.1-)
- inhalant dependence (F18.2-)
Medical Intelligence & Overview
Inhalant use, classified under ICD-10 code F18.9, refers to the consumption of volatile substances through inhalation. These substances are often accessible household products or chemicals that provide a quick, if risky, way to experience a psychoactive effect. Inhalant misuse can pose serious health dangers, leading to both short-term intoxication and long-term health complications.
Causes & Symptoms
Clinical Causes: Poverty or socioeconomic difficulties Exploration or experimentation, especially among adolescents and young adults Peer pressure or social influences Mental health conditions such as depression or anxiety Lack of awareness about the risks associated with inhalant use Availability of common household products containing inhalants
Key Symptoms: Sudden intoxication with feelings of euphoria or dizziness Slurred speech and impaired coordination Nausea or vomiting Headaches or lightheadedness Confusion or disorientation Respiratory issues like coughing or wheezing Eye irritation or tearing Unconsciousness in severe cases Behavior changes or signs of intoxication such as reckless actions
Diagnostic & Treatment
Diagnosis Path: Diagnosis of inhalant use typically involves a comprehensive health assessment, including a thorough medical history and physical examination. Medical professionals may inquire about exposure to household chemicals or solvents. Laboratory tests, such as blood or urine analysis, can detect the presence of inhalant substances or their metabolites. Additionally, observing physical signs and symptoms helps healthcare providers assess the severity and impact of inhalant use.
Treatment Protocols: Treatment strategies for inhalant use focus on addressing both the physical and psychological aspects. Immediate medical attention may be required in cases of intoxication or overdose to manage symptoms and prevent complications such as suffocation or cardiac issues. Long-term treatment often involves counseling or behavioral therapy to tackle underlying causes and prevent relapse. Support groups and community resources can also aid recovery, along with education about the risks associated with inhalant substances.
Clinical Advice & FAQs
Billing Guidance
Is F18.9 a billable ICD-10 code?
Yes, F18.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.9?
Clinical documentation must specify the nature of Inhalant use, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference